EUVIMEDEUVIMED entdecken
Crossref

Impact of Interferon on the Prognosis of Hepatitis C Virus-Related Hepatocellular Carcinoma Patients with a Sustained Virological Response –An Additional Comparison Between Preoperative and Postoperative Sustained Virological Response

Daisuke Muroya, Taro Nishimura, Hiroki Kanno, Satoki Kojima, Shogo Fukutomi, Masanori Akashi, Yoriko Nomura, Yuichi Goto, Toshihiro Sato, Hisamune Sakai, Toru Hisaka, Yoshito Akagi und 1 weitere

The Kurume Medical Journal · 2021

DOI: 10.2739/kurumemedj.ms681001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kurume Medical Journal, 2021. Verfasst von Daisuke Muroya und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kurume University School of Medicine. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Several studies have reported that interferon (IFN) therapy improves the prognosis of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), especially for patients who have achieved a sustained virological response (SVR). We retrospectively evaluated the clinicopathological outcomes of patients who acquired an SVR through IFN therapy pre- or post-hepatectomy for treatment naïve HCC. METHOD: Among the 305 HCV-related HCC patients entered in this study, 59 patients (SVR group) achieved an SVR after IFN therapy and received hepatectomy either after or before achieving an SVR (n=36 and n=23, respectively), while the remaining 179 patients (control group) did not receive IFN therapy, or did not achieve an SVR through IFN therapy (n=67). RESULTS: In the SVR group, the overall survival (OS) and disease-free survival (DFS) rates were significantly higher than in the control group. We evaluated the prognosis of patients with an SVR achieved pre- or post-hepatectomy separately. There were no significant differences in OS and DFS. CONCLUSION: This result suggests that the prognosis of naïve HCC may be improved by additional INF therapy to achieve SVR status after hepatectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis CHepatitis C, ChronicHumansInterferonsHepacivirusAntiviral AgentsRetrospective StudiesNeoplasm Recurrence, LocalPrognosis

Stichwörter der Autor:innen

hepatectomyhepatitis C virushepatocellular carcinomainterferon therapysustained virological response

Substanzen

InterferonsAntiviral Agents

Autor:innen und Institutionen

  • Department of Surgery, Kurume University School of Medicine.

Zitieren

APA

Muroya, D., Nishimura, T., Kanno, H., Kojima, S., Fukutomi, S., Akashi, M., Nomura, Y., Goto, Y., Sato, T., Sakai, H., Hisaka, T., Akagi, Y., & Okuda, K. (2021). Impact of Interferon on the Prognosis of Hepatitis C Virus-Related Hepatocellular Carcinoma Patients with a Sustained Virological Response –An Additional Comparison Between Preoperative and Postoperative Sustained Virological Response. The Kurume Medical Journal. https://doi.org/10.2739/kurumemedj.ms681001

Vancouver

Muroya D, Nishimura T, Kanno H, Kojima S, Fukutomi S, Akashi M, et al. Impact of Interferon on the Prognosis of Hepatitis C Virus-Related Hepatocellular Carcinoma Patients with a Sustained Virological Response –An Additional Comparison Between Preoperative and Postoperative Sustained Virological Response. The Kurume Medical Journal. 2021. doi:10.2739/kurumemedj.ms681001

BibTeX
@article{Muroya2021,
  author = {Muroya, Daisuke and Nishimura, Taro and Kanno, Hiroki and Kojima, Satoki and Fukutomi, Shogo and Akashi, Masanori and Nomura, Yoriko and Goto, Yuichi and Sato, Toshihiro and Sakai, Hisamune and Hisaka, Toru and Akagi, Yoshito and Okuda, Koji},
  title = {Impact of Interferon on the Prognosis of Hepatitis C Virus-Related Hepatocellular Carcinoma Patients with a Sustained Virological Response –An Additional Comparison Between Preoperative and Postoperative Sustained Virological Response},
  journal = {The Kurume Medical Journal},
  year = {2021},
  doi = {10.2739/kurumemedj.ms681001}
}
Kostenlos starten →